Nomic Bio

Montréal, Canada

Drug Discovery/Development

At Nomic, we are making protein profiling broadly accessible. At the heart of our platform is the nELISA, a proprietary technology that enables massive multiplexing with true flexibility, full quantification, and unmatched cost-efficiency. Nomic has developed the most comprehensive solution for inflammation research that allows for the high-throughput quantification of hundreds of secreted proteins. Nomic is rapidly expanding its biological footprint to cover proteins across the entire proteome, unlocking new possibilities for diverse applications, uses cases, and disease areas.